Mustang Bio
MBIO
83 hedge funds and large institutions have $46.4M invested in Mustang Bio in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 17 reducing their positions, and 9 closing their positions.
94% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 17
56% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 9
5% more funds holding
Funds holding: 79 → 83 (+4)
0% more ownership
Funds ownership: 0.04% → 0.04% (+0%)
15% less call options, than puts
Call options by funds: $137K | Put options by funds: $161K
35% less capital invested
Capital invested by funds: $71.8M → $46.4M (-$25.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.63M |
| 2 |
BlackRock
New York
|
+$1.59M |
| 3 |
Renaissance Technologies
New York
|
+$1.52M |
| 4 |
D.E. Shaw & Co
New York
|
+$413K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$161K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$1.19M |
| 2 |
Two Sigma Advisers
New York
|
-$899K |
| 3 |
Two Sigma Investments
New York
|
-$488K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$281K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$124K |
MBIO Hedge Fund Activity: Q4 2021 in Review
83 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q4 2021, worth a combined $46.4M — down 35% from $71.8M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new MBIO positions and 9 closed out — a net gain of 5 holders — while 33 added to existing stakes and 17 trimmed.
The largest buyer was GSA Capital Partners, adding an estimated $1.63M. The largest seller was Russell Investments Group, exiting entirely with an estimated $1.19M sold.
- 83 institutional investors held Mustang Bio (MBIO) as of Q4 2021, up from 79 in Q3 2021.
- Funds reported $46.4M of Mustang Bio stock for Q4 2021, down 35% quarter-over-quarter.
- 14 funds opened new Mustang Bio positions in Q4 2021 and 9 closed out, a net change of +5 holders.
- The largest Mustang Bio buyer in Q4 2021 was GSA Capital Partners, an estimated $1.63M added.
- The largest Mustang Bio seller in Q4 2021 was Russell Investments Group, an estimated $1.19M sold.
Based on aggregated 13F filings for Q4 2021.